The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...
A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback